SBRT Shows Favorable Long-Term Outcomes and Low Severe Toxicity in Studies May 12, 2017 Stereotactic body radiotherapy (SBRT) has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment option for men with low- and intermediate-risk prostate cancer, according to three studies recently presented at the 36th European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting.Read more.Source: Prostate Cancer News Today Prostate Cancer News
Stereotactic body radiotherapy (SBRT) has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment option for men with low- and intermediate-risk prostate cancer, according to three studies recently presented at the 36th European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting.Read more.Source: Prostate Cancer News Today
